Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS) (Q37788728)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on September 15, 2010

Language	Label	Description	Also known as
English	Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS)	scientific article published on September 15, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS) (English)

reason for preferred rank

most precise value

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Role of antiischemic agents in the management of non-ST elevation acute coronary syndrome (NSTE-ACS) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840192

12 July 2024

acute coronary syndrome

1 reference

based on heuristic

inferred from title

Moutaz El Kadri

1

object named as

Moutaz El-Kadri

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840192

12 July 2024

author name string

Hala Sharaf-Dabbagh

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

David Ramsdale

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20840192

12 July 2024

publication date

15 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-5922.2010.00225.x

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1755-5922.2010.00225.x

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Cardiovascular Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

e16-22

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Optimal medical therapy with or without PCI for stable coronary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Progression of atheroma: a struggle between death and procreation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Bivalirudin for patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Evolving mechanisms of action of beta blockers: focus on nebivolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Expert consensus document on beta-adrenergic receptor blockers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Cardiac excitation-contraction coupling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Comparison of short-term efficacy of diltiazem and propranolol in unstable angina at rest—A randomized trial in 70 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Verapamil use in patients with cardiovascular disease: an overview of randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Intravenous nitroglycerine in refractory unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

K(ATP) channel therapeutics at the bedside

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Angina reassessed: pain or protector?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

The cardiac pacemaker current

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

Trimetazidine for stable angina

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003614.PUB2

Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006

3

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort

9

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

17

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Tissue-factor antigen and activity in human coronary atherosclerotic plaques

21

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

30

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Adrenergic and muscarinic receptors in the human heart

34

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias

40

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Effect of beta blockers on expression of interleukin-6 and C-reactive protein in patients with unstable angina pectoris

41

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI Trial Research Group

44

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT)

45

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group

47

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Usefulness of carvedilol in unstable angina pectoris

48

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial

49

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

51

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Per

54

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Local control of excitation-contraction coupling in rat heart cells

58

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Trial of early nifedipine in acute myocardial infarction: the Trent study

62

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina

67

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Verapamil versus propranolol for angina at rest

68

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group

70

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

71

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

73

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms

76

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action

78

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study

80

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Molecular Mechanism of Action of Nicorandil

85

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas

90

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less

94

1 reference

10.1111/J.1755-5922.2010.00225.X

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Identifiers

10.1111/J.1755-5922.2010.00225.X

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37788728&oldid=2202734625"